YTHDF2 and hepatocellular carcinoma: Besides, quantitative real‐time PCR (qRT‐PCR) (for cohort 1), western blotting (for cohort 1) and immunohistochemistry (IHC) analyses (for cohort 2) in paired tumor and adjacent nontumorous tissues (ANT) confirmed the expression pattern of YTHDF2 in HCC (Figure 1A–C; Figure S1E,F and Table S1, Supporting Information).